Masayoshi Oikawa
About
Masayoshi Oikawa is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology.
According to data from OpenAlex, Masayoshi Oikawa has authored 144 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Cardiology and Cardiovascular Medicine, 33 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Masayoshi Oikawa's work include Cardiovascular Function and Risk Factors (48 papers), Heart Failure Treatment and Management (34 papers) and Pulmonary Hypertension Research and Treatments (15 papers). Masayoshi Oikawa is often cited by papers focused on Cardiovascular Function and Risk Factors (48 papers), Heart Failure Treatment and Management (34 papers) and Pulmonary Hypertension Research and Treatments (15 papers). Masayoshi Oikawa collaborates with scholars based in Japan, United States and United Kingdom. Masayoshi Oikawa's co-authors include Yasuchika Takeishi, Akiomi Yoshihisa, Atsushi Kobayashi, Takamasa Sato, Takayoshi Yamaki, Hiroyuki Kunii, Kazuhiko Nakazato, Tetsuro Yokokawa, Tomofumi Misaka and Satoshi Suzuki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
In The Last Decade
Masayoshi Oikawa
135 papers receiving 2.3k citations
Peers
Masayoshi Oikawa
Akiomi Yoshihisa Japan
Takanori Arimoto Japan
Eiichiro Yamamoto Japan
Hiroyuki Kunii Japan
Masayuki Takamura Japan
Kaisa Mäki-Petäjä United Kingdom
Yu Sato Japan
Takayoshi Yamaki Japan
Bernhard M. Kaess Germany
Maria Perticone Italy
Citations per year, relative to Masayoshi Oikawa Masayoshi Oikawa (= 1×)
peers
Akiomi Yoshihisa
Countries citing papers authored by Masayoshi Oikawa
Since
Specialization
Citations
This map shows the geographic impact of Masayoshi Oikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayoshi Oikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayoshi Oikawa more than expected).
Fields of papers citing papers by Masayoshi Oikawa
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Masayoshi Oikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayoshi Oikawa. The network helps show where Masayoshi Oikawa may publish in the future.
Co-authorship network of co-authors of Masayoshi Oikawa
This figure shows the co-authorship network connecting the top 25 collaborators of Masayoshi Oikawa. A scholar is included among the top collaborators of Masayoshi Oikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayoshi Oikawa. Masayoshi Oikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Yokokawa, Tetsuro, Shunsuke Miura, Akihiko Sato, et al.. (2025). Targeting colony-stimulating factor-1 receptor attenuates the development of pulmonary arterial hypertension through C-C motif chemokine ligand 2. American Journal of Respiratory Cell and Molecular Biology. 74(3). 295–310.
2.
Abe, Satoshi, Akiomi Yoshihisa, Yu Sato, et al.. (2024). Calcium-Phosphorus Product Is Associated with Adverse Prognosis in Hospitalized Patients with Heart Failure and Chronic Kidney Disease. International Heart Journal. 65(1). 84–93.
3.
Oikawa, Masayoshi, et al.. (2024). Intracardiac Thrombus Associated With Heparin-Induced Thrombocytopenia in a Patient With Patent Foramen Ovale. Circulation Journal. 88(9). 1501–1501.
4.
Misaka, Tomofumi, Yu Sato, Yusuke Tomita, et al.. (2024). Elevated Blood Bicarbonate Levels and Long-Term Adverse Outcomes in Patients with Chronic Heart Failure. ESC Heart Failure. 11(6). 4420–4426.
5.
Tomita, Yusuke, Tomofumi Misaka, Yu Sato, et al.. (2024). Reduced Fetuin‐A Levels Are Associated With Exercise Intolerance and Predict the Risk of Adverse Outcomes in Patients With Heart Failure: The Role of Cardiac–Hepatic–Peripheral Interaction. Journal of the American Heart Association. 13(17). e035139–e035139.
6.
Sato, Akihiko, Yu Sato, Takeshi Shimizu, et al.. (2024). Predictive Value of Aortic Valve Calcium Volume Measured by Computed Tomography for Paravalvular Leakage After Transcatheter Aortic Valve Implantation. International Heart Journal. 65(1). 63–70.
7.
Misaka, Tomofumi, Yusuke Tomita, Yu Sato, et al.. (2024). Neutrophil Extracellular Traps in Myocardial Tissue Drive Cardiac Dysfunction and Adverse Outcomes in Patients With Heart Failure With Dilated Cardiomyopathy. Circulation Heart Failure. 17(6). e011057–e011057.
8.
Nakazato, Kazuhiko, Koichi Sugimoto, Masayoshi Oikawa, & Yasuchika Takeishi. (2023). Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension:its history and development, and regional medical cooperation in Fukushima. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE. 69(3). 167–176.
9.
Nakazato, Kazuhiko, Tetsuro Yokokawa, Yoshinori Suzuki, et al.. (2023). A Case of Giant Goiter Associated with Airway Stenosis Caused by Long-Term Intravenous Epoprostenol Therapy for Idiopathic Pulmonary Arterial Hypertension. Journal of Clinical Medicine. 12(19). 6359–6359.
10.
Fukushima, Kenji, Shiro Ishii, Osamu Hasegawa, et al.. (2023). Global and Regional Reduction of Myocardial Perfusion in Patients with Transthyretin Type of Cardiac Amyloidosis. PubMed. 10(1). 16–22.
11.
Misaka, Tomofumi, Akiomi Yoshihisa, Yu Sato, et al.. (2023). Prognostic significance of spleen shear wave elastography and dispersion in patients with heart failure: the crucial role of cardio-splenic axis. Clinical Research in Cardiology. 112(7). 942–953.
12.
Yoshihisa, Akiomi, Yu Sato, Yusuke Kimishima, et al.. (2021). Cardio-Ankle Vascular Index Reflects Impaired Exercise Capacity and Predicts Adverse Prognosis in Patients With Heart Failure. Frontiers in Cardiovascular Medicine. 8. 631807–631807.
13.
Oikawa, Masayoshi, Akiomi Yoshihisa, Yu Sato, et al.. (2020). Prognostic impact of moderate mitral regurgitation on hospitalized heart failure patients with preserved ejection fraction: A report from the JASPER registry. Heart and Vessels. 35(8). 1087–1094.
14.
Sato, Yu, Akiomi Yoshihisa, Yusuke Kimishima, et al.. (2020). B-Type Natriuretic Peptide is Associated with Post-Discharge Stroke in Hospitalized Patients with Heart Failure. ESC Heart Failure. 7(5). 2508–2515.
15.
Yoshihisa, Akiomi, Yu Sato, Tetsuro Yokokawa, et al.. (2020). Intrarenal Doppler ultrasonography reflects hemodynamics and predicts prognosis in patients with heart failure. Scientific Reports. 10(1). 22257–22257.
16.
Sato, Yu, Akiomi Yoshihisa, Masayoshi Oikawa, et al.. (2019). Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction – A report from the JASPER registry. Journal of Cardiology. 73(6). 459–465.
17.
Sato, Yu, Akiomi Yoshihisa, Masayoshi Oikawa, et al.. (2019). Prognostic Impact of Worsening Renal Function in Hospitalized Heart Failure Patients With Preserved Ejection Fraction: A Report From the JASPER Registry. Journal of Cardiac Failure. 25(8). 631–642.
18.
Yoshihisa, Akiomi, Takatoyo Kiko, Takamasa Sato, et al.. (2018). Urinary N-terminal fragment of titin is a marker to diagnose muscular dystrophy in patients with cardiomyopathy. Clinica Chimica Acta. 484. 226–230.
19.
Watanabe, Shunsuke, Akiomi Yoshihisa, Yuki Kanno, et al.. (2016). Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients. Journal of Cardiac Failure. 22(12). 962–969.
20.
Abe, Satoshi, Akiomi Yoshihisa, Mai Takiguchi, et al.. (2014). Liver Dysfunction Assessed by Model for End-Stage Liver Disease Excluding INR (MELD-XI) Scoring System Predicts Adverse Prognosis in Heart Failure. PLoS ONE. 9(6). e100618–e100618.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Akiomi Yoshihisa Breakdown of academic impact, for papers by Takanori Arimoto Breakdown of academic impact, for papers by Eiichiro Yamamoto Breakdown of academic impact, for papers by Hiroyuki Kunii Breakdown of academic impact, for papers by Masayuki Takamura Breakdown of academic impact, for papers by Kaisa Mäki-Petäjä Breakdown of academic impact, for papers by Yu Sato Breakdown of academic impact, for papers by Takayoshi Yamaki Breakdown of academic impact, for papers by Bernhard M. Kaess Breakdown of academic impact, for papers by Maria Perticone